DE434633C - Process for the preparation of a Drosera extract which contains the active ferments and is particularly active in arteriosclerosis - Google Patents

Process for the preparation of a Drosera extract which contains the active ferments and is particularly active in arteriosclerosis

Info

Publication number
DE434633C
DE434633C DEM84670D DEM0084670D DE434633C DE 434633 C DE434633 C DE 434633C DE M84670 D DEM84670 D DE M84670D DE M0084670 D DEM0084670 D DE M0084670D DE 434633 C DE434633 C DE 434633C
Authority
DE
Germany
Prior art keywords
drosera
active
extract
arteriosclerosis
ferments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEM84670D
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VLADISLAV MLADEJOVSKY DR
Original Assignee
VLADISLAV MLADEJOVSKY DR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VLADISLAV MLADEJOVSKY DR filed Critical VLADISLAV MLADEJOVSKY DR
Application granted granted Critical
Publication of DE434633C publication Critical patent/DE434633C/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)

Description

Verfahren zur Herstellung eines die wirksamen Fermente enthaltenden, besonders bei Arteriosklerose wirksamen Droseraextraktes. Bekanntlich dient die wäßrige Auskochung des Sonnentau (Drosera rotundifolia) als Hausmittel gegen Arteriosklerose. Bei dieser Auskochung leiden aber größtenteils die wirksamen Substanzen (proteolytische Fermente), da dieselben so hohe Temperaturen nicht vertragen.Process for the production of a containing the active ferments, Drosera extract, particularly effective in arteriosclerosis. As is well known, the Aqueous decoction of sundew (Drosera rotundifolia) as a home remedy for arteriosclerosis. In this decoction, however, the active substances (proteolytic Ferments), as they cannot tolerate such high temperatures.

Gegenstand der vorliegenden Erfindung ist die Herstellung eines Extraktes aus Drosera rotundifolia, in welchem die wirksamen Fermente vollständig erhalten sind.The present invention relates to the production of an extract from Drosera rotundifolia, in which the effective ferments are completely preserved are.

Erfindungsgemäß erfolgt die Extraktion statt durch kochendes Wasser durch eine etwa '/2prozentige Lösung von kieselsaurem Natron. Zwecks Geschmackverbesserung wird der Lösung etwas Zucker zugesetzt. Die Autolyse ist derart vorzunehmen, daß die freie Kieselsäure in Lösung bleibt. Der Extrakt wird sodann in bekannter Weise im Vakuum eingedickt, wobei die Temperatur von 40' C nicht überschritten werden soll. Die Konzentration wird so lange fortgesetzt, als die Kieselsäure noch in Lösung bleibt, wobei eine Lösung erhalten wird, die ungefähr im Kubikzentimeter t mg Si(OH)4 enthält. In seiner therapeutischen Wirkung übertrifft das neue Präparat bei weitem die Wirkung des kieselsauren Natriums und die Wirkung des bekannten Droseraextraktes.According to the invention, the extraction takes place instead of by boiling water by an approximately 1/2 percent solution of silicic acid soda. To improve the taste a little sugar is added to the solution. The autolysis is to be carried out in such a way that the free silica remains in solution. The extract is then made in a known manner thickened in vacuo, the temperature of 40 ° C. not being exceeded target. The concentration is continued as long as the silica is still in solution remains, whereby a solution is obtained which is approximately in cubic centimeters t mg Si (OH) 4 contains. The new preparation is far superior in its therapeutic effect the effect of the silica sodium and the effect of the well-known Drosera extract.

Claims (1)

PATENT-ANSPRUcH: Verfahren zur Herstellung eines die wirksamen Fermente enthaltenden, besonders bei Arteriosklerose wirksamen Droseraextraktes, dadurch gekennzeichnet, daß fein zermahlene Drosera rotundifolia einer Extraktion mittels einer Lösung von kieselsaurem Natrium unter Vermeidung der Ausfällung der Kieselsäure unterzogen wird, worauf die Lösung in bekannter Weise im Vakuum bis zu einer solchen Konzentration eingedickt wird, daß die Kieselsäure eben noch gelöst bleibt.PATENT CLAIM: Process for the production of one of the most effective ferments containing Drosera extract, which is particularly effective in arteriosclerosis, thereby characterized in that finely ground Drosera rotundifolia means of extraction a solution of silicic acid sodium avoiding the precipitation of the silicic acid is subjected, whereupon the solution in a known manner in a vacuum up to such Concentration is thickened so that the silica just remains dissolved.
DEM84670D 1923-12-28 1924-04-23 Process for the preparation of a Drosera extract which contains the active ferments and is particularly active in arteriosclerosis Expired DE434633C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS434633X 1923-12-28

Publications (1)

Publication Number Publication Date
DE434633C true DE434633C (en) 1926-10-01

Family

ID=5452838

Family Applications (1)

Application Number Title Priority Date Filing Date
DEM84670D Expired DE434633C (en) 1923-12-28 1924-04-23 Process for the preparation of a Drosera extract which contains the active ferments and is particularly active in arteriosclerosis

Country Status (1)

Country Link
DE (1) DE434633C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019808A1 (en) * 1979-05-22 1980-12-10 Keller, Helmut, Dr.med. Medicine against cancer
EP0249165A2 (en) * 1986-06-07 1987-12-16 Carnivora Forschungs-GmbH Medicine for combating malignant and chronic diseases
WO1999042115A1 (en) * 1998-02-23 1999-08-26 Carnivora Forschungs-Gmbh Use of a press-juice, digestive juice or extract of carnivorous plants for inhibiting protein kinases

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019808A1 (en) * 1979-05-22 1980-12-10 Keller, Helmut, Dr.med. Medicine against cancer
EP0249165A2 (en) * 1986-06-07 1987-12-16 Carnivora Forschungs-GmbH Medicine for combating malignant and chronic diseases
EP0249165A3 (en) * 1986-06-07 1988-03-09 Helmut Dr.Med. Keller Medicine for combating malignant and chronic diseases
WO1999042115A1 (en) * 1998-02-23 1999-08-26 Carnivora Forschungs-Gmbh Use of a press-juice, digestive juice or extract of carnivorous plants for inhibiting protein kinases

Similar Documents

Publication Publication Date Title
DE434633C (en) Process for the preparation of a Drosera extract which contains the active ferments and is particularly active in arteriosclerosis
DE644078C (en) Process for the preparation of a salt of 4-oxy-3-acetylaminophenyl-1-arsic acid with the toxin of iso-octylhydrocupreine (vuzinotoxin)
US1579828A (en) Process for producing a preparation for treating arteriosclerosis
AT107852B (en) Process for the production of a Drosera extract which contains the active ferments and is particularly active in arteriosclerosis.
DE568339C (en) Process for the production of a silver-containing preparation from ethylene diamine
AT52848B (en) Process for the production of preparations for diagnostic and curative purposes from pure cultures of the pathogens recognized as specific for the individual disease.
DE423225C (en) Process for making bread and pastries
DE413380C (en) Process for the preparation of pure 1-nitro-2-methylanthraquinone
AT148983B (en) Process for the preparation of readily soluble dialkali salts of 4-oxy-3-acylaminobenzolaric acids (1).
AT112135B (en) Process for the preparation of basic oxime ethers and their salts.
DE582245C (en) Process for the preparation of basic particles of catechol
AT124720B (en) Process for the production of water-soluble silicic acid-protein compounds.
DE469554C (en) Process for the preparation of a bismuth alkaline tartrate
DE638822C (en) Process for the preparation of the crystallized dye from the yellow oxidizing ferment
DE614337C (en) Process for the preparation of a calcium salt solution suitable for injection
CH276621A (en) Process for the preparation of p-amino-salicylic acid-n-butylmide.
CH195072A (en) Process for the production of a new azo dye.
CH155458A (en) Process for the preparation of a brown wool dye.
CH197183A (en) Process for the production of a vat dye.
CH173293A (en) Process for the preparation of a cyanine dye.
GB252099A (en) Improvements in or relating to the preparation of soluble salts of substituted phenyl-arsinic acids
CH178751A (en) Process for the production of an acidic dye of the Safranin series.
CH276620A (en) Process for the preparation of p-amino-salicylic acid-n-propylamide.
CH166095A (en) Process for the production of an easily soluble, basic dye.
CH193260A (en) Process for the production of an acidic wool dye.